Company Filing History:
1 out of 190 
1 out of 153 Years Active: 2025
Title: Lingbo Zhang: Innovator in Anemia Treatment
Introduction
Lingbo Zhang is a notable inventor based in Woodside, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of anemia. His innovative approach focuses on the use of muscarinic acetylcholine receptor subtype 4 antagonists to promote the self-renewal of burst forming unit erythroid (BFU-E) cells.
Latest Patents
Lingbo Zhang holds a patent for "Muscarinic acetylcholine receptor subtype 4 antagonists in the treatment of anemia." This patent relates to the use of small molecule compounds to effectively treat anemias by enhancing the self-renewal of BFU-E cells. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Lingbo Zhang has worked with prestigious institutions such as Cold Spring Harbor Laboratory and The Feinstein Institutes for Medical Research. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Lingbo Zhang has collaborated with Yousef Al Abed, further enhancing his research capabilities and expanding the impact of his work in the medical community.
Conclusion
Lingbo Zhang's innovative contributions to anemia treatment through his patented research highlight his role as a significant inventor in the medical field. His work continues to inspire advancements in healthcare and improve patient outcomes.